Chief Financial Officer
Tycho Peterson is the Chief Financial Officer of Adaptive Biotechnologies, a commercial-stage biotech company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease. Tycho brings several decades of financial leadership and experience within the life science and diagnostic industries to Adaptive. Prior to joining Adaptive, Tycho spent 23 years at JP Morgan Chase, where he was most recently the managing director of life science tools and diagnostics in the healthcare group. He holds an MSc/MBA degree in biology and business administration from the University of Oxford and a BS in biology from Cornell University.